PPARG and colitis: The authors also showed that the polysaccharide-modulated key signaling pathways, including the NF-κB, MAPK, and PPARγ signaling pathways, inhibited the NLRP3 inflammasome signaling pathway, resulting in a reduction in DSS-induced colitis inflammation.